Schematic Brief Outline: Bulimia Nervosa and its Medical-Based Management

Yash Srivastav *

Azad Institute of Pharmacy and Research, Lucknow, U.P, India.

Mohd Faijan Mansoori

Azad Institute of Pharmacy and Research, Lucknow, U.P, India.

Aditya Srivastav

Institute of Pharmacy Bundelkhand University, Kanpur Road Jhansi, Uttar Pradesh, India.

Aniket Kumar

Institute of Pharmacy Bundelkhand University, Kanpur Road Jhansi, Uttar Pradesh, India.

*Author to whom correspondence should be addressed.


The disease known as bulimia nervosa, which is typified by purging and binge eating, usually starts in adolescence and peaks at the age of 18. The ratio of female to male patients varies from 10:1 to 20:1, with a lifetime frequency of 3 per cent. The majority of bulimic individuals also suffer from other mental illnesses, such as depression or anxiety. Additionally, there is a correlation between substance misuse and promiscuity. Bulimia nervosa was initially identified as a "chronic phase of anorexia nervosa" in 1979 by British psychiatrist Gerald Russell. During this stage, patients overeat and resort to compensatory methods such as self-induced vomiting, laxatives, or extended periods of deprivation. For three months, bingeing and purging episodes occurring at least once a week are typically associated with a bulimia diagnosis. However, even infrequent binge and purge behaviours can be harmful and require medical attention. The severity of the bulimia increases with the frequency of the bouts. Family therapy and individual treatment are frequently used to treat bulimia. The goal is to address any dietary issues and modify your behaviour. The relationship between your thoughts, feelings, and behaviours is examined in therapy. We go over the aetiology, epidemiology, current treatment, and state of bulimia nervosa in this review study.

Keywords: Bulimia nervosa, epidemiology, diagnosis, current treatment

How to Cite

Srivastav , Yash, Mohd Faijan Mansoori, Aditya Srivastav, and Aniket Kumar. 2024. “Schematic Brief Outline: Bulimia Nervosa and Its Medical-Based Management”. International Neuropsychiatric Disease Journal 21 (4):61-65.


Download data is not yet available.


Van Eeden AE, Van Hoeken D, Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry. 2021;34(6): 515–24.

Meytin D. Bulimia nervosa: Literature review. Med Sci. 2021;9(7):123–9.

Motwani S, Karia S, Mandalia B, Desousa A. Eating disorders in India: An overview. Ann Indian Psychiatry. 2021;5(1):12.

Elshazly ARE, Seleem MA, Abo-Ryia M H, Badawy AAK. Study on Psychiatric Evaluation of Morbidly Obese Patients. International Neuropsychiatric Disease Journal. 2021;16(2):8–16.


Castillo M, Weiselberg E. Bulimia Nervosa/Purging Disorder. Curr Probl Pediatr Adolesc Health Care. 2017; 47(4):85–94.

Wu J, Lin Z, Liu Z, He H, Bai L, Lyu J. Secular trends in the incidence of eating disorders in China from 1990 to 2017: a joinpoint and age–period–cohort analysis. Psychol Med. 2022;52(5):946–956.

Wang S, Chen L, Chen X, Wei G. Joint quantisation levels and power optimisation in uplink network multiple-input and multiple-output under constraint backhaul. IET Commun. 2015;9(16):2041–7.

Treatment of patients with eating disorders,third edition. American Psychiatric Association. Am J Psychiatry. 2006;163(7Suppl):4–54.

Jain A, Yilanli M. Bulimia Nervosa. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

Available: 2024;562178.

Yager J. Psychosocial Treatments for Eating Disorders. Psychiatry (New York). 1994;57(2):153–64.

Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord. 2007;40(4):321–36.

Pope HGJ, Keck PEJ, McElroy SL, Hudson JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol. 1989;9(4):254–9.

Horne RL, Ferguson JM, Pope HGJ, Hudson JI, Lineberry CG, Ascher J, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry. 1988;49(7):262–6.

Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord. 2005;38(4):295–300.

Hay P, Bacaltchuk J. Bulimia nervosa. Clin Evid (Online). 2003;(10):1070–84.